Market Closed -
Other stock markets
|
Pre-market 04:58:31 pm | |||
30.72 USD | -0.58% | 31.08 | +1.16% |
10/05 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.95% | 142.99Cr | |
+37.74% | 72TCr | |
+34.69% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+17.21% | 24TCr | |
+9.99% | 21TCr | |
-4.13% | 21TCr | |
+7.43% | 17TCr |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- RBC Trims Pacira BioSciences' Price Target to $80 From $82, Keeps Outperform Rating